Related Experiment Video
Updated: Jun 15, 2026

07:16
DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition
Published on: February 9, 2024
DNA-based nano-sized systems for pharmaceutical and biomedical applications.
Makiya Nishikawa1, Sakulrat Rattanakiat, Yoshinobu Takakura
1Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. makiya@pharm.kyoto-u.ac.jp
Advanced Drug Delivery Reviews
|March 17, 2010
Summary
DNA nanotechnology enables new biomaterials, but their interaction with the body is unclear. This study reviews DNA molecule delivery and explores how structured DNA assemblies interact with Toll-like receptor-9 (TLR9) in cells.
Area of Science:
- Biotechnology
- Nanotechnology
- Immunology
Background:
- Deoxyribonucleic acid (DNA) is crucial for genetic information transmission in all living organisms.
- Advances in DNA handling allow its use as a building block for precisely engineered nano-sized materials.
- Understanding DNA assemblies' biological interactions is vital for pharmaceutical and biomedical applications.
Purpose of the Study:
- To review challenges in administering DNA molecules externally, focusing on stability, permeability, and delivery.
- To investigate the interaction between structured DNA assemblies and biological components, particularly Toll-like receptor-9 (TLR9).
Main Methods:
- Literature review of DNA molecule administration and stability.
- Analysis of cellular responses to structured DNA assemblies.
- Focus on Toll-like receptor-9 (TLR9) mediated recognition of unmethylated CpG dinucleotides.
Main Results:
- Externally administered DNA molecules face stability, permeability, and delivery hurdles.
- Structured DNA assemblies elicit specific cellular responses.
- Toll-like receptor-9 (TLR9) plays a key role in recognizing DNA assemblies containing unmethylated CpG motifs.
Conclusions:
- Effective delivery and stability are critical for DNA-based nanomedicines.
- The interaction of DNA assemblies with TLR9 influences their biological impact.
- Further research into DNA assembly-cell interactions is essential for advancing nanomedicine.

